Merck drug under review in EU after trial failure

LONDON (Reuters) - The future of Merck & Co's cholesterol drug Tredaptive is under review in Europe - where it is already approved - following the failure of the medicine in a key study, the region's regulator said on Thursday. Any decision to pull the drug from the market in Europe would be a blow to Merck's reputation, although the commercial impact would be limited. ... via Health News Headlines - Yahoo! News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/12/merck-drug-under-review-in-eu-after.html